Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1

被引:122
作者
de Witte, Lot
Bobardt, Michael
Chatterji, Udayan
Degeest, Gisele
David, Guido
Geijtenbeek, Teunis B. H.
Gallay, Philippe
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] VU Amsterdam Univ, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands
[3] Katholieke Univ Leuven VIB, Dept Human Genet, B-3000 Louvain, Belgium
关键词
D O I
10.1073/pnas.0703747104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dendritic cells (DCs) efficiently capture HIV-1 and mediate transmission to T cells, but the underlying molecular mechanism is still being debated. The C-type lectin DC-SIGN is important in HIV-1 transmission by DCs. However, various studies strongly suggest that another HIV-1 receptor on DCs is involved in the capture of HIV-1. Here we have identified syndecan-3 as a major HIV-1 attachment receptor on DCs. Syndecan-3 is a DC-specific heparan sulfate (HS) proteoglycan that captures HIV-1 through interaction with the HIV-1 envelope glycoprotein gp120. Syndecan-3 stabilizes the captured virus, enhances DC infection in cis, and promotes transmission to T cells. Removal of the HSs from the cell surface by heparinase III or by silencing syndecan-3 by siRNA partially inhibited HIV-1 transmission by immature DCs, whereas neutralizing both syndecan-3 and DC-SIGN completely abrogated HIV-1 capture and subsequent transmission. Thus, HIV-1 exploits both syndecan-3 and DC-SIGN to mediate HIV-1 transmission, and an effective microbicide should target both syndecan-3 and DC-SIGN on DCs to prevent transmission.
引用
收藏
页码:19464 / 19469
页数:6
相关论文
共 49 条
[21]   HEPARAN-SULFATE PROTEOGLYCANS [J].
GALLAGHER, JT ;
TURNBULL, JE ;
LYON, M .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (02) :207-209
[22]   Syndecans and HIV-1 pathogenesis [J].
Gallay, P .
MICROBES AND INFECTION, 2004, 6 (06) :617-622
[23]   HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway [J].
Gallay, P ;
Hope, T ;
Chin, D ;
Trono, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9825-9830
[24]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[25]   Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction [J].
Granelli-Piperno, A ;
Pritsker, A ;
Pack, M ;
Shimeliovich, I ;
Arrighi, JF ;
Park, CG ;
Trumpfheller, C ;
Piguet, V ;
Moran, TM ;
Steinman, RM .
JOURNAL OF IMMUNOLOGY, 2005, 175 (07) :4265-4273
[26]   Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway [J].
Gummuluru, S ;
Rogel, M ;
Stamatatos, L ;
Emerman, M .
JOURNAL OF VIROLOGY, 2003, 77 (23) :12865-12874
[27]   Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa [J].
Gurney, KB ;
Elliott, J ;
Nassanian, H ;
Song, C ;
Soilleux, E ;
McGowan, I ;
Anton, PA ;
Lee, B .
JOURNAL OF VIROLOGY, 2005, 79 (09) :5762-5773
[28]   Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120 [J].
Hong, Patrick W. -P. ;
Nguyen, Sandra ;
Young, Sophia ;
Su, Stephen V. ;
Lee, Benhur .
JOURNAL OF VIROLOGY, 2007, 81 (15) :8325-8336
[29]   Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques [J].
Jameson, B ;
Baribaud, F ;
Pöhlmann, S ;
Ghavimi, D ;
Mortari, F ;
Doms, RW ;
Iwasaki, A .
JOURNAL OF VIROLOGY, 2002, 76 (04) :1866-1875
[30]   DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection [J].
Kwon, DS ;
Gregorio, G ;
Bitton, N ;
Hendrickson, WA ;
Littman, DR .
IMMUNITY, 2002, 16 (01) :135-144